Full-Time

Vice President

Global Market Access, Cell Therapy

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Advanced degree in life sciences, business administration, or a related field; MBA preferred.
  • 15+ years in market access, with a focus on cell therapies or biologics, including leadership roles. Significant market building and launch experience required. Small company experience preferred.
  • In-depth understanding of the healthcare landscape, payer dynamics, and reimbursement processes, including inpatient/outpatient reimbursement, US payer value and pricing as well as EU HTA and coverage dynamics.
  • Strong analytical, strategic thinking, and communication skills. Proven ability to lead teams and manage complex projects. Proven ability to develop and enhance product value propositions with US and EU payer audiences.
  • Established relationships with key industry stakeholders and decision-makers across the US payer landscape.
Responsibilities
  • Develop and implement market access strategies that align with corporate goals and drive the successful launch and commercialization of cell therapies.
  • Build and maintain relationships with key stakeholders, including payers, healthcare providers, and policymakers, to advocate for reimbursement and access.
  • Conduct comprehensive market assessments to identify trends, opportunities, and challenges in the cell therapy landscape.
  • Develop and oversee reimbursement strategies, including value-based pricing models, to ensure optimal reimbursement for products.
  • Ensure that all market access strategies comply with relevant regulations and guidelines.
  • Collaborate with R&D, commercial, clinical, and regulatory teams to align market access strategies with product development and commercialization plans.
  • Oversee the market access budget and resources to ensure effective implementation of strategies.
  • Lead and mentor a team of market access professionals, fostering a collaborative and results-oriented environment.

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to advance cell therapy treatments, addressing conditions that currently have limited effective options.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

11%

1 year growth

16%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?